BNET Industries has undergone a redesign. It looks better and, more importantly, traffic is up. Most things are in the same place they always were, so you can still read my stuff about the pharmaceutical industry here, and my stuff about the advertising business here.
Nonetheless, there are a couple of things that readers might want to note in order to get the most out of the site. First, if you want to see more than five of my “Analysis” posts at a time, click on the black box where it says “more posts.” A longer ladder of headlines will unscroll automatically.
Second, if you want to click backward through everything I’ve written chronologically, then try this URL for BNET Pharma and this one for BNET Advertising. This will give you a more traditional “blog”-style experience.
I’d love to hear your feedback.
You’ll also notice that fewer BNET posts of mine link back to this blog for extra resources such as documentary source material. That’s because the new BNET edit interface made it easier for me to upload documents directly into BNET.com.
Lastly, access to BNET’s feedback tools got stricter. Now, you have to register with the site before voting for stories or commenting on them. This has had the immediate effect of making it look like fewer people are checking BNET stories as “favorites” and fewer people are commenting. BNET has done this for business reasons; registered readers are more important to advertisers (and BNET’s editorial staff) than random anonymous readers.
From your point of view, this means that if you take the trouble to register and vote or comment, your contribution is taken much more seriously than it is elsewhere where any anonymous person can say whatever nonsense they wish. Those of you who have commented on my items or sent me emails know that I almost always respond when warranted, even to critics.
Thanks for reading. We study the stats every day — and thank you for showing up.